C. Semeraro

1.3k total citations
34 papers, 1.0k citations indexed

About

C. Semeraro is a scholar working on Molecular Biology, Physiology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, C. Semeraro has authored 34 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 10 papers in Physiology and 7 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in C. Semeraro's work include Receptor Mechanisms and Signaling (10 papers), Nitric Oxide and Endothelin Effects (8 papers) and Neuropeptides and Animal Physiology (5 papers). C. Semeraro is often cited by papers focused on Receptor Mechanisms and Signaling (10 papers), Nitric Oxide and Endothelin Effects (8 papers) and Neuropeptides and Animal Physiology (5 papers). C. Semeraro collaborates with scholars based in Italy, United Kingdom and United States. C. Semeraro's co-authors include Cédric Blanpain, Gaëlle Lapouge, Antoine Bondue, Michael Kyba, Michelina Iacovino, Catherine Paulissen, Gilbert M. Eisner, Pedro A. José, Laureano D. Asico and Robin A. Felder and has published in prestigious journals such as Journal of Clinical Investigation, Nature Cell Biology and Cell stem cell.

In The Last Decade

C. Semeraro

34 papers receiving 997 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Semeraro Italy 12 707 190 144 130 128 34 1.0k
Katsushi Shibata Japan 17 495 0.7× 127 0.7× 105 0.7× 67 0.5× 144 1.1× 29 854
Renata I. Dmitrieva Russia 17 736 1.0× 167 0.9× 160 1.1× 177 1.4× 226 1.8× 52 1.2k
N. E. Owen United States 19 811 1.1× 191 1.0× 247 1.7× 89 0.7× 74 0.6× 31 1.2k
Ikuyo Yamaguchi United States 15 515 0.7× 230 1.2× 98 0.7× 94 0.7× 223 1.7× 29 1.0k
William K. Sonnenburg United States 15 790 1.1× 403 2.1× 181 1.3× 41 0.3× 196 1.5× 16 1.1k
Wilhelm Erdbrügger Germany 13 615 0.9× 147 0.8× 120 0.8× 229 1.8× 42 0.3× 15 1.1k
Tengis S. Pavlov United States 23 791 1.1× 194 1.0× 156 1.1× 105 0.8× 331 2.6× 53 1.4k
Gertraud Hanft Germany 18 858 1.2× 127 0.7× 201 1.4× 54 0.4× 76 0.6× 27 1.4k
Jennifer L. Busch United States 5 421 0.6× 173 0.9× 330 2.3× 62 0.5× 65 0.5× 9 864
Ke Dong United States 19 1.1k 1.6× 157 0.8× 83 0.6× 131 1.0× 94 0.7× 31 1.4k

Countries citing papers authored by C. Semeraro

Since Specialization
Citations

This map shows the geographic impact of C. Semeraro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Semeraro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Semeraro more than expected).

Fields of papers citing papers by C. Semeraro

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Semeraro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Semeraro. The network helps show where C. Semeraro may publish in the future.

Co-authorship network of co-authors of C. Semeraro

This figure shows the co-authorship network connecting the top 25 collaborators of C. Semeraro. A scholar is included among the top collaborators of C. Semeraro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Semeraro. C. Semeraro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sotiropoulou, Panagiota A., Aurélie Candi, Guilhem Mascré, et al.. (2010). Bcl-2 and accelerated DNA repair mediates resistance of hair follicle bulge stem cells to DNA-damage-induced cell death. Nature Cell Biology. 12(6). 572–582. 199 indexed citations
2.
Bondue, Antoine, Gaëlle Lapouge, Catherine Paulissen, et al.. (2008). Mesp1 Acts as a Master Regulator of Multipotent Cardiovascular Progenitor Specification. Cell stem cell. 3(1). 69–84. 287 indexed citations
3.
Luca, Danièle De, et al.. (2007). Attempt to improve transcutaneous bilirubinometry: a double-blind study of Medick BiliMed versus Respironics BiliCheck. Archives of Disease in Childhood Fetal & Neonatal. 93(2). F135–F139. 20 indexed citations
4.
Zeng, Chunyu, Laureano D. Asico, Xiaoguang Sun, et al.. (2001). Impaired renal D1-like and D2-like dopamine receptor interaction in the spontaneously hypertensive rat. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 281(4). R1071–R1078. 61 indexed citations
5.
Bollard, Mary E., et al.. (2000). Pharmacokinetics and disposition of the novel dopamine agonist Z-7760 in rat after intravenous and oral administration. Xenobiotica. 30(10). 983–991. 1 indexed citations
6.
Asico, Laureano D., Sara Fuchs, Domenico Accili, et al.. (1998). Disruption of the dopamine D3 receptor gene produces renin-dependent hypertension.. Journal of Clinical Investigation. 102(3). 493–498. 144 indexed citations
7.
Spina, Domenico, et al.. (1998). The effect duration of selective phosphodiesterase inhibitors in the guinea pig. Life Sciences. 62(11). 953–965. 11 indexed citations
8.
Marchini, Francesco, et al.. (1998). Pharmacological evidence for the presence of a peripheral postjunctional D2‐like dopamine receptor in rabbit splenic artery. British Journal of Pharmacology. 123(4). 730–736. 3 indexed citations
9.
Semeraro, C., et al.. (1997). The Role of Dopaminergic Agonists in Congestive Heart Failure. Clinical and Experimental Hypertension. 19(1-2). 201–215. 10 indexed citations
10.
Emerson, Michael, et al.. (1997). Effects of dopamine and selective dopamine agonists upon platelet accumulation in the cerebral and pulmonary vasculature of the rabbit. British Journal of Pharmacology. 122(4). 682–686. 8 indexed citations
11.
Santangelo, Francesco, et al.. (1997). Novel Selective Thiol Inhibitors of Neutral Endopeptidase Containing Heterocycles at P'2Position. Journal of enzyme inhibition. 12(2). 155–160. 2 indexed citations
12.
Moriggi, Ermanno, et al.. (1996). The effect of selective phosphodiesterase 3 and 4 isoenzyme inhibitors and established anti‐asthma drugs on inflammatory cell activation. British Journal of Pharmacology. 119(6). 1255–1261. 46 indexed citations
13.
Bertolini, Giorgio, et al.. (1996). Z1046, a novel peripheral dopaminergic agent. Bioorganic & Medicinal Chemistry Letters. 6(22). 2795–2800. 5 indexed citations
14.
Marchini, Francesco, et al.. (1995). Characterization of Big Endothelin-1-Induced Contraction in Rabbit Saphenous Artery. Journal of Cardiovascular Pharmacology. 26. S78–80. 3 indexed citations
15.
16.
Marchini, Francesco, et al.. (1995). Peripheral dopaminergic activity of Z1046, a new mixed D1-like/D2-like-receptors agonist. Pharmacological Research. 31. 243–243. 5 indexed citations
17.
Semeraro, C., et al.. (1990). Peripheral vascular and neuronal effects of dopamine receptor agonists. A comparison with receptor binding studies in rat striatum. Naunyn-Schmiedeberg s Archives of Pharmacology. 342(5). 539–46. 9 indexed citations
18.
Casagrande, C, et al.. (1989). Cardiovascular and Renal Action of Dopaminergic Prodrugs. Journal of Cardiovascular Pharmacology. 14. S40–S59. 16 indexed citations
19.
Semeraro, C., et al.. (1989). Renal function studies with cadralazine in conscious dogs: A comparison with hydralazine. Pharmacological Research. 21(2). 211–222. 3 indexed citations
20.
Dorigotti, L. & C. Semeraro. (1980). Renal function studies with propildazine alone and in combination with propranolol in dogs. European Journal of Pharmacology. 67(2-3). 275–282. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026